Luis Diaz-Rubio Amate
Managing Director, Emerging Markets at EMEA Janssen, pharmaceuticals division of Johnson & Johnson
- 16 January
- BUDGET BALANCE OF THE FUTURE HEALTHCARE Building 5, Floor 5, Assembly Hall
Luis Diaz-Rubio was appointed Managing Director, Emerging Markets EMEA in September, 2015 for Janssen EMEA, one of the pharmaceutical companies of Johnson & Johnson. In his role, he is responsible for driving growth and leading the strategy for Janssen operations in Africa, Middle East and Turkey. He also serves as a member of the European Leadership Team (ELT). He represents Janssen in the Executive Committee of the Middle East & Africa branch of the Pharmaceutical Research and Manufacturers of America (PhRMA).
Luis started his career at Janssen in 1997, assuming several roles in sales and marketing before becoming Sales & Marketing Director, first for the Neuroscience and Primary care franchises, and thereafter for all commercial products. In 2011, he joined Janssen Portugal as General Manager driving growth for the company during a challenging economic period. In 2012, he moved to Janssen Brazil as Managing Director, where he spent three years. During that period, Janssen Brazil achieved solid growth and entered in key partnership agreements with the Brazilian Minister of Health.
Luis, a native of Madrid, Spain, holds a degree in Business Administration from the Universidad Autónoma de Madrid and a MBA from Loyola University of Chicago. He speaks Spanish, English and Portuguese and now lives in Madrid, Spain, with his wife and four children.